SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘10-K’ for 12/31/12 – ‘R24’

On:  Wednesday, 2/6/13, at 6:00pm ET   ·   As of:  2/7/13   ·   For:  12/31/12   ·   Accession #:  731766-13-5   ·   File #:  1-10864

Previous ‘10-K’:  ‘10-K’ on 2/9/12 for 12/31/11   ·   Next:  ‘10-K’ on 2/12/14 for 12/31/13   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/07/13  Unitedhealth Group Inc            10-K       12/31/12  114:25M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.52M 
 2: EX-10.11    Material Contract                                   HTML     38K 
 3: EX-10.32    Material Contract                                   HTML     78K 
 4: EX-10.33    Material Contract                                   HTML     82K 
 5: EX-10.36    Material Contract                                   HTML    104K 
 6: EX-10.37    Material Contract                                   HTML     35K 
 8: EX-21.1     Subsidiaries List                                   HTML    229K 
 9: EX-23.1     Consent of Experts or Counsel                       HTML     34K 
10: EX-24.1     Power of Attorney                                   HTML     43K 
 7: EX-12.1     Statement re: Computation of Ratios                 HTML     47K 
11: EX-31.1     Certification -- §302 - SOA'02                      HTML     50K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     38K 
78: R1          Document and Entity Information Document            HTML     62K 
63: R2          Condensed Consolidated Balance Sheets               HTML    164K 
74: R3          Condensed Consolidated Balance Sheet                HTML     69K 
                (Parenthetical) (Parentheticals)                                 
82: R4          Condensed Consolidated Statements of Operations     HTML    125K 
104: R5          Condensed Consolidated Statements of Comprehensive  HTML     92K  
                Income                                                           
65: R6          Condensed Consolidated Statements of Changes in     HTML    109K 
                Shareholders' Equity                                             
73: R7          Condensed Consolidated Statements of Cash Flows     HTML    173K 
57: R8          Description of Business                             HTML     38K 
47: R9          Basis of Presentation                               HTML    206K 
106: R10         Investments                                         HTML    270K  
84: R11         Fair Value                                          HTML    336K 
83: R12         Property, Equipment, and Capitalized Software       HTML     59K 
90: R13         Goodwill and Intangible Assets                      HTML    140K 
91: R14         Medical Costs and Medical Costs Payable             HTML     70K 
88: R15         Commercial Paper and Long-Term Debt                 HTML    216K 
92: R16         Income Taxes                                        HTML    158K 
75: R17         Shareholder's Equity                                HTML     65K 
79: R18         Share-Based Compensation                            HTML    119K 
86: R19         Commitments and Contingencies                       HTML     58K 
114: R20         Segment Financial Information                       HTML    307K  
100: R21         Quarterly Financial Data (Unaudited)                HTML     82K  
69: R22         Schedule I                                          HTML    195K 
85: R23         Basis of Presentation (Policy)                      HTML    185K 
71: R24         Fair Value Fair Value Policy (Policies)             HTML     50K 
38: R25         Income Taxes Income Tax (Policies)                  HTML     44K 
101: R26         Shareholder's Equity Shareholder's Equity           HTML     48K  
                (Policies)                                                       
110: R27         Share-Based Compensation Recognition (Policies)     HTML     52K  
52: R28         Segment Financial Information Segment Financial     HTML     43K 
                Information (Policies)                                           
51: R29         Basis of Presentation Basis of Presentation         HTML     75K 
                (Tables)                                                         
55: R30         Investments (Tables)                                HTML    268K 
56: R31         Fair Value (Tables)                                 HTML    324K 
58: R32         Property, Equipment, and Capitalized Software       HTML     58K 
                Property, Equipment, and Capitalized Software                    
                (Tables)                                                         
27: R33         Goodwill and Intangible Assets Goodwill and         HTML    141K 
                Intangible Assets(Tables)                                        
98: R34         Medical Costs and Medical Costs Payable Medical     HTML     72K 
                Cost Development (Tables)                                        
67: R35         Commercial Paper and Long-Term Debt (Tables)        HTML    210K 
70: R36         Income Taxes Income Tax (Tables)                    HTML    155K 
42: R37         Shareholder's Equity Shareholder's Equity (Tables)  HTML     43K 
113: R38         Share-Based Compensation (Tables)                   HTML    117K  
19: R39         Commitments and Contingencies Commitments and       HTML     46K 
                Contingencies (Tables)                                           
60: R40         Segment Financial Information (Tables)              HTML    292K 
103: R41         Quarterly Financial Data (Unaudited) Quarterly      HTML     80K  
                Financial Data (Unaudited) (Tables)                              
40: R42         Schedule I Schedule I (Tables)                      HTML    196K 
50: R43         Basis of Presentation Basis of Presentation Useful  HTML     37K 
                lives for property, equipment and capitalized                    
                software (Details)                                               
54: R44         Basis of Presentation Basis of Presentation         HTML     39K 
                Medicare Part D (Details)                                        
64: R45         Basis of Presentation Basis of Presentation         HTML     93K 
                Narrative (Details)                                              
26: R46         Investments (Narrative) (Details)                   HTML     37K 
46: R47         Investments (Short-Term and Long-Term Investments)  HTML     91K 
                (Details)                                                        
22: R48         Investments (Fair Value of Mortgage-Backed          HTML     54K 
                Securities by Credit Rating Origination) (Details)               
102: R49         Investments (Amortized Cost and Fair Value of       HTML     80K  
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
39: R50         Investments (Amortized Cost and Fair Value of       HTML     67K 
                Held-To-Maturity Debt Securities by Contractual                  
                Maturity) (Details)                                              
99: R51         Investments (Fair Value of Available-For-Sale       HTML     63K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
43: R52         Investments (Net Realized Gains) (Details)          HTML     55K 
61: R53         Fair Value (Narrative) (Details)                    HTML     57K 
21: R54         Fair Value (Financial Assets and Liabilities,       HTML     76K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
24: R55         Fair Value (Financial Assets and Liabilities,       HTML     58K 
                Excluding AARP, Not Measured at Fair Value on a                  
                Recurring Basis) (Details)                                       
53: R56         Fair Value (Reconciliation of Assets Measured at    HTML     62K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
31: R57         Fair Value (Assets and Liabilities measured at      HTML     78K 
                fair value on a recurring basis) (Details)                       
107: R58         Fair Value Fair Value Inputs Assets Quantitative    HTML     43K  
                Information (Details)                                            
66: R59         Property, Equipment, and Capitalized Software       HTML     41K 
                Property, Equipment, and Capitalized Software                    
                Narrative (Details)                                              
89: R60         Property, Equipment, and Capitalized Software       HTML     63K 
                Property, Equipment, and Capitalized Software                    
                table (Details)                                                  
45: R61         Goodwill and Intangible Assets Goodwill and         HTML     90K 
                Intangible Assets Narrative (Details)                            
48: R62         Goodwill and Intangible Assets Goodwill (Changes    HTML     61K 
                in the Carrying Amount of Goodwill by Reporting                  
                Segment) (Details)                                               
96: R63         Goodwill and Intangible Assets Goodwill (Net        HTML     62K 
                Tangible Assets Acquired in Amil Acquisition)                    
                (Details)                                                        
93: R64         Goodwill and Intangible Assets Goodwill and Other   HTML     54K 
                Intangible Assets Gross carrying value,                          
                accumulated amortization and net carrying value of               
                intangible assets (Details)                                      
68: R65         Goodwill and Intangible Assets Goodwill and Other   HTML     44K 
                Intangible Assets Weighted-average useful lives                  
                assigned to finite-lived intangible assets                       
                acquired in business combinations (Details)                      
95: R66         Goodwill and Intangible Assets Goodwill and Other   HTML     43K 
                Intangible Assets Amortization Expense relating to               
                Intangible Assets (Details)                                      
44: R67         Medical Costs and Medical Costs Payable (Details)   HTML     35K 
72: R68         Medical Costs and Medical Costs Payable Medical     HTML     58K 
                Costs and Medical Costs Payable Rollforward                      
                (Details)                                                        
109: R69         Commercial Paper and Long-Term Debt (Narrative)     HTML     96K  
                (Details)                                                        
23: R70         Commercial Paper and Long-Term Debt (Commercial     HTML    107K 
                Paper and Long-Term Debt) (Details)                              
37: R71         Commercial Paper and Long-Term Debt Commercial      HTML     51K 
                Paper and Long-Term Debt Maturities of commercial                
                paper and long-term debt (Details)                               
62: R72         Income Taxes Income Tax Narrative (Details)         HTML     53K 
29: R73         Income Taxes Income Taxes Components of the         HTML     59K 
                provision for income taxes (Details)                             
112: R74         Income Taxes Income Taxes Reconciliation of the     HTML     81K  
                tax provision at the U.S. Federal Statutory Rate                 
                to the provision for income taxes (Details)                      
41: R75         Income Taxes Income taxes components of deferred    HTML    105K 
                tax assets and liabilities (Details)                             
32: R76         Income Taxes Income Taxes Reconciliation of the     HTML     53K 
                beginning and ending amount of unrecognized tax                  
                benefits (Details)                                               
36: R77         Shareholder's Equity Shareholder's Equity           HTML     80K 
                (Details)                                                        
25: R78         Share-Based Compensation (Narrative) (Details)      HTML     40K 
28: R79         Share-Based Compensation (Stock Option and SAR      HTML     88K 
                Activity) (Details)                                              
80: R80         Share-Based Compensation (Restricted Share          HTML     62K 
                Activity) (Details)                                              
34: R81         Share-Based Compensation Other Share-Based          HTML     69K 
                Compensation Data (Details)                                      
108: R82         Share-Based Compensation (Share-Based Compensation  HTML     52K  
                Principal Fair Value Assumptions) (Details)                      
59: R83         Commitments and Contingencies (Details)             HTML     41K 
87: R84         Commitments and Contingencies Future Lease          HTML     55K 
                Payments (Details)                                               
94: R85         Segment Financial Information (Details)             HTML    147K 
33: R86         Segment Financial Information Segment Financial     HTML     42K 
                Information (Narrative) (Details)                                
35: R87         Quarterly Financial Data (Unaudited) Quarterly      HTML     62K 
                Financial Data (Unaudited) (Details)                             
105: R88         Schedule I (Details)                                HTML     56K  
30: R89         Schedule I Schedule I Condensed Balance Sheet       HTML    117K 
                (Details)                                                        
81: R90         Schedule I Schedule I Condensed Balanch Sheet       HTML     59K 
                (Parentheticals) (Details)                                       
77: R91         Schedule I Schedule I Condensed Statment of         HTML     90K 
                Operations (Details)                                             
97: R92         Schedule I Schedule I Statement of Cash Flows       HTML    105K 
                (Details)                                                        
76: R93         Schedule I Parent Commercial Paper and Long-Term    HTML     48K 
                Debt Maturities of commercial paper and long-term                
                debt (Details)                                                   
111: XML         IDEA XML File -- Filing Summary                      XML    178K  
49: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   4.30M 
13: EX-101.INS  XBRL Instance -- unh-20121231                        XML   6.42M 
15: EX-101.CAL  XBRL Calculations -- unh-20121231_cal                XML    305K 
16: EX-101.DEF  XBRL Definitions -- unh-20121231_def                 XML   1.35M 
17: EX-101.LAB  XBRL Labels -- unh-20121231_lab                      XML   2.60M 
18: EX-101.PRE  XBRL Presentations -- unh-20121231_pre               XML   1.67M 
14: EX-101.SCH  XBRL Schema -- unh-20121231                          XSD    274K 
20: ZIP         XBRL Zipped Folder -- 0000731766-13-000005-xbrl      Zip    462K 


‘R24’   —   Fair Value Fair Value Policy (Policies)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.0.6
Fair Value Fair Value Policy (Policies)
12 Months Ended
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments, Policy [Policy Text Block]
Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability.
The fair value hierarchy is summarized as follows:
Level 1 — Quoted prices (unadjusted) for identical assets/liabilities in active markets.
Level 2 — Other observable inputs, either directly or indirectly, including:
Quoted prices for similar assets/liabilities in active markets;
Quoted prices for identical or similar assets/liabilities in non-active markets (e.g., few transactions, limited information, non-current prices, high variability over time);
Inputs other than quoted prices that are observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and
Inputs that are corroborated by other observable market data.
Level 3 — Unobservable inputs that cannot be corroborated by observable market data.
Transfers between levels, if any, are recorded as of the beginning of the reporting period in which the transfer occurs; there were no transfers between Levels 1, 2 or 3 of any financial assets or liabilities during 2012 or 2011.
Non-financial assets and liabilities or financial assets and liabilities that are measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. There were no significant fair value adjustments for these assets and liabilities recorded during the years ended December 31, 2012, 2011, and 2010.
The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:
Cash and Cash Equivalents. The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.
Debt and Equity Securities. Fair values of debt and equity securities are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs that are currently observable in the markets for similar securities. Inputs that are often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and non-binding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to a secondary pricing source, prices reported by its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company’s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment in the prices obtained from the pricing service.
Fair values of debt securities that do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level 2.
Fair value estimates for Level 1 and Level 2 equity securities are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices.
The Company’s Level 3 equity securities are primarily investments in venture capital securities. The fair values of Level 3 investments in venture capital portfolios are estimated using a market valuation technique that relies heavily on management assumptions and qualitative observations. Under the market approach, the fair values of the Company’s various venture capital investments are computed using limited quantitative and qualitative observations of activity for similar companies in the current market. The Company’s market modeling utilizes, as applicable, transactions for comparable companies in similar industries and having similar revenue and growth characteristics; and similar preferences in their capital structure. Key significant unobservable inputs in the market technique include implied earnings before interest, taxes, depreciation and amortization (EBITDA) multiples and revenue multiples. Additionally, the fair value of certain of the Company’s venture capital securities are based off of recent transactions in inactive markets for identical or similar securities. Significant changes in any of these inputs could result in significantly lower or higher fair value measurements.
Throughout the procedures discussed above in relation to the Company’s processes for validating third party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on that understanding.
AARP Program-related Investments. AARP Program-related investments consist of debt and equity securities held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company’s debt and equity securities.
Interest Rate and Currency Swaps. Fair values of the Company’s swaps are estimated using the terms of the swaps and publicly available information including market yield curves. Because the swaps are unique and not actively traded but are valued using other observable inputs, the fair values are classified as Level 2.
Long-term debt. The fair value of the Company’s long-term debt is estimated and classified using the same methodologies as the Company’s investments in debt securities.
AARP Program-related Other Liabilities. AARP Program-related other liabilities consist of liabilities that represent the amount of net investment gains and losses related to AARP Program-related investments that accrue to the benefit of the AARP policyholders.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/7/13
Filed on:2/6/134
For Period end:12/31/1211-K,  3,  ARS
9/15/09
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/24/23  UnitedHealth Group Inc.           10-K       12/31/22  119:19M
 2/15/22  UnitedHealth Group Inc.           10-K       12/31/21  113:19M
 3/01/21  UnitedHealth Group Inc.           10-K       12/31/20  107:17M
 5/22/13  SEC                               UPLOAD10/06/17    1:34K  Unitedhealth Group Inc.
 3/21/13  SEC                               UPLOAD10/06/17    1:161K Unitedhealth Group Inc.
Top
Filing Submission 0000731766-13-000005   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 9:39:03.1am ET